• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • In?Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

In?Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells.

In?Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells. Cancer Invest. 2020 Jul; 38(6):349-355.

View in: PubMed

subject areas
  • Apoptosis
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • Benzimidazoles
  • Caspase 3
  • Cell Line, Tumor
  • Cell Proliferation
  • Checkpoint Kinase 2
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Meningioma
  • Mutation
  • Neoplasm Staging
  • Neurofibromin 2
  • Phosphatidylinositol 3-Kinases
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-akt
  • Quinolones
  • Receptors, Fibroblast Growth Factor
  • Signal Transduction

authors with profiles
  • Arabinda Das
  • Sunil J. Patel
  • William Alexander Vandergrift
  • Abhay K. Varma
  • Scott Michael Lindhorst
  • David Maria Cachia
  • Libby Kosnik Infinger